Effect of ammonia on the anaerobic degradation of protein by a mesophilic and thermophilic biowaste population.
The influence of ammonia on the anaerobic degradation of peptone by mesophilic and thermophilic populations of biowaste was investigated. For peptone concentrations from 5 g l-1 to 20 g l-1 the mesophilic population revealed a higher rate of deamination than the thermophilic population, e.g. 552 mg l-1 day-1 compared to 320 mg l-1 day-1 at 10 g l-1 peptone. The final degree of deamination of the thermophilic population was, however, higher: 102 compared to 87 mg NH3/g peptone in the mesophilic cultures. If 0.5-6.5 g l-1 ammonia was added to the mesophilic biowaste cultures, deamination of peptone, degradation of its chemical oxygen demand (COD) and formation of biogas were increasingly inhibited, but no hydrogen was formed. The thermophilic biowaste cultures were most active if around 1 g ammonia l-1 was present. Deamination, COD degradation and biogas production decreased at lower and higher ammonia concentrations and hydrogen was formed in addition to methane. Studies of the inhibition by ammonia of peptone deamination, COD degradation and methane formation revealed a Ki (50%) for NH3 of 92, 95 and 88 mg l-1 at 37 degrees C and 251, 274 and 297 mg l-1 at 55 degrees C respectively. This indicated that the thermophilic flora tolerated significantly more NH3 than the mesophilic flora. In the mesophilic reactor effluent 4.6 x 10(8) peptone-degrading colony-forming units (cfu)/ml were culturable, whereas in the thermophilic reactor effluent growth of only 5.6 x 10(7) cfu/ml was observed.
Gallert
C
C
Institut für Ingenieurbiologie und Biotechnologie des Abwassers, Universität Karlsruhe, Germany.
Bauer
S
S
Winter
J
J
D000588:Amines / Q000378:metabolism; D000641:Ammonia / Q000032:analysis / Q000494:pharmacology*; D000693:Anaerobiosis; D001419:Bacteria / Q000187:drug effects* / Q000378:metabolism; D001673:Biodegradation, Environmental / Q000187:drug effects; D019149:Bioreactors; D006859:Hydrogen / Q000032:analysis; D008697:Methane / Q000032:analysis / Q000037:antagonists & inhibitors; D010100:Oxygen / Q000493:pharmacokinetics; D010461:Peptones / Q000037:antagonists & inhibitors / Q000378:metabolism; D011506:Proteins / Q000378:metabolism*; D013997:Time Factors
D000588:Amines; D010461:Peptones; D011506:Proteins; D000641:Ammonia; D006859:Hydrogen; D008697:Methane; D010100:Oxygen